AAV Gene Therapy for the Treatment of GSD VI and IX a2: Determination of Efficacy between Duke Plasmids and Kriya Plasmids for restoring PYGL and PHKA2 (the "Project") Addendum #8
Research Grant
Administered By
Pediatrics, Medical Genetics
Awarded By
Kriya Therapeutics
Start Date
October 13, 2022
End Date
May 31, 2024
Administered By
Pediatrics, Medical Genetics
Awarded By
Kriya Therapeutics
Start Date
October 13, 2022
End Date
May 31, 2024